RU2131876C1 - Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения - Google Patents
Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения Download PDFInfo
- Publication number
- RU2131876C1 RU2131876C1 RU96103653A RU96103653A RU2131876C1 RU 2131876 C1 RU2131876 C1 RU 2131876C1 RU 96103653 A RU96103653 A RU 96103653A RU 96103653 A RU96103653 A RU 96103653A RU 2131876 C1 RU2131876 C1 RU 2131876C1
- Authority
- RU
- Russia
- Prior art keywords
- oxo
- ethyl
- pyridine
- pyrazolo
- tetrahydro
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8829293A | 1993-07-06 | 1993-07-06 | |
US08/088,292 | 1993-07-06 | ||
PCT/IB1994/000156 WO1995001980A1 (en) | 1993-07-06 | 1994-06-16 | Bicyclic tetrahydro pyrazolopyridines |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96103653A RU96103653A (ru) | 1998-05-10 |
RU2131876C1 true RU2131876C1 (ru) | 1999-06-20 |
Family
ID=22210524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96103653A RU2131876C1 (ru) | 1993-07-06 | 1994-06-16 | Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения |
Country Status (20)
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2230553C2 (ru) * | 1997-09-26 | 2004-06-20 | Центарис АГ | Способ модулирования функции серин/треонин протеинкиназы соединением на основе азабензимидазола, способ идентификации соединений, модулирующих функцию серин/треонин протеинкиназы, способ профилактики или лечения патологических состояний в организме, соединение на основе азабензимидазола, способ его синтеза и фармацевтическая композиция |
RU2317988C2 (ru) * | 2000-08-14 | 2008-02-27 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные пиразолы, фармацевтическая композиция на их основе, применение фармацевтической композиции и способ ингибирования активности катепсина s |
RU2345993C2 (ru) * | 2001-09-21 | 2009-02-10 | Бристол-Маерс Сквибб Компани | ЛАКТАМСОДЕРЖАЩЕЕ СОЕДИНЕНИЕ И ЕГО ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa |
RU2390522C2 (ru) * | 2004-08-03 | 2010-05-27 | Палау Фарма, С.А. | Гетероциклические соединения |
RU2780338C2 (ru) * | 2017-05-31 | 2022-09-21 | Кемосентрикс, Инк. | 6-5 КОНДЕНСИРОВАННЫЕ КОЛЬЦА КАК ИНГИБИТОРЫ С5а |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ292991A (en) * | 1994-10-20 | 1999-02-25 | Pfizer | Bicyclic tetrahydropyrazolopyridines that are selective inhibitors of phosphodiesterase (pde) type iv or the production of tnf and pharmaceutical compositions containing them |
CA2223624C (en) * | 1995-06-06 | 2001-02-20 | Pfizer Inc. | Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
AP932A (en) * | 1996-08-26 | 2001-02-02 | Pfizer | Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines. |
EA002113B1 (ru) * | 1996-09-04 | 2001-12-24 | Пфайзер Инк. | Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно) |
KR100628407B1 (ko) * | 1998-12-23 | 2006-09-26 | 브리스톨-마이어스 스퀴브 파마 컴파니 | Xa 인자 억제제로서의 질소 함유 헤테로비시클릭 화합물 |
US6858616B2 (en) | 1998-12-23 | 2005-02-22 | Bristol-Myers Squibb Pharma Company | Nitrogen containing heterobicycles as factor Xa inhibitors |
US6326495B2 (en) | 1999-04-30 | 2001-12-04 | Pfizer Inc. | Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein |
PL200923B1 (pl) | 1999-08-21 | 2009-02-27 | Nycomed Gmbh | Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu |
TWI243055B (en) * | 2000-04-13 | 2005-11-11 | Nippon Zoki Pharmaceutical Co | Pharmaceutical composition for use in treatment of dermatitis |
HU229824B1 (en) * | 2000-08-10 | 2014-08-28 | Pfizer Italia Srl | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
US6960595B2 (en) * | 2001-03-23 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | 5-6 to 5-7 Heterobicycles as factor Xa inhibitors |
US6750225B2 (en) | 2001-04-18 | 2004-06-15 | Bristol-Myers Squibb Pharms Company | 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors |
CA2441772A1 (en) | 2001-04-18 | 2002-10-31 | Bristol-Myers Squibb Company | 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors |
EP1396493A4 (en) | 2001-04-26 | 2005-08-03 | Ajinomoto Kk | HETEROCYCLIC COMPOUNDS |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
WO2004076450A1 (en) | 2003-02-27 | 2004-09-10 | J. Uriach Y Compañia S.A. | Pyrazolopyridine derivates |
US7135469B2 (en) * | 2003-03-18 | 2006-11-14 | Bristol Myers Squibb, Co. | Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors |
CA2517487A1 (en) | 2003-04-01 | 2004-10-14 | Applied Research Systems Ars Holding N.V. | Inhibitors of phosphodiesterases in infertility |
US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
DE102005031580A1 (de) * | 2005-07-06 | 2007-01-11 | Aicuris Gmbh & Co. Kg | Substituierte Sulfolanylpyrazole und ihre Verwendung |
PE20081889A1 (es) * | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA3100941C (en) | 2011-03-01 | 2024-03-05 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
EP3718557A3 (en) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
CN114404588A (zh) | 2013-08-09 | 2022-04-29 | 阿德利克斯公司 | 用于抑制磷酸盐转运的化合物和方法 |
CN110357888A (zh) * | 2018-04-09 | 2019-10-22 | 南京药捷安康生物科技有限公司 | 杂环磷酸二酯酶抑制剂及其用途 |
CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1463883A (fr) * | 1964-09-08 | 1966-07-22 | Ciba Geigy | Procédé de préparation de triaza-composés bicycliques |
US4419359A (en) * | 1981-02-11 | 1983-12-06 | Richter Gedeon Vegyeszeti Gyar Rt | Nitro-substituted polycyclic derivatives useful in the treatment of psoriasis |
US4450164A (en) * | 1981-01-13 | 1984-05-22 | Schering Corporation | Imidazo[1,2-A]pyridines and use |
US4492695A (en) * | 1982-04-21 | 1985-01-08 | Synthelabo | Therapeutically useful imidazo[1,2-a]pyridine derivatives |
SU1450746A3 (ru) * | 1985-04-25 | 1989-01-07 | Бристоль-Мейерз Компани (Фирма) | Способ получени производных 1,3-дигидро-2Н-имидазо/4,5-в/хинолин-2-онов или их фармацевтически приемлемых солей |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3365459A (en) | 1964-09-08 | 1968-01-23 | Ciba Geigy Corp | Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives |
US3340269A (en) * | 1964-09-08 | 1967-09-05 | Ciba Geigy Corp | 1-substituted 4-acyl-2, 3-dioxo-piperidine |
US5356897A (en) * | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
-
1994
- 1994-06-16 BR BR9406946A patent/BR9406946A/pt not_active Application Discontinuation
- 1994-06-16 NZ NZ266525A patent/NZ266525A/en unknown
- 1994-06-16 EP EP94916370A patent/EP0707585A1/en not_active Withdrawn
- 1994-06-16 KR KR1019960700019A patent/KR100228949B1/ko not_active Expired - Fee Related
- 1994-06-16 PL PL94312426A patent/PL312426A1/xx unknown
- 1994-06-16 CA CA002166721A patent/CA2166721C/en not_active Expired - Fee Related
- 1994-06-16 JP JP7503938A patent/JP2944048B2/ja not_active Expired - Lifetime
- 1994-06-16 CZ CZ9636A patent/CZ3696A3/cs unknown
- 1994-06-16 HU HU9503934A patent/HUT74170A/hu unknown
- 1994-06-16 AU AU68057/94A patent/AU695301B2/en not_active Ceased
- 1994-06-16 CN CN94193233A patent/CN1048015C/zh not_active Expired - Fee Related
- 1994-06-16 WO PCT/IB1994/000156 patent/WO1995001980A1/en not_active Application Discontinuation
- 1994-06-16 RU RU96103653A patent/RU2131876C1/ru active
- 1994-06-17 TW TW083105518A patent/TW316904B/zh active
- 1994-06-30 IL IL11017594A patent/IL110175A/xx active IP Right Grant
- 1994-07-05 EG EG40294A patent/EG20513A/xx active
- 1994-07-05 FI FI943208A patent/FI943208L/fi unknown
- 1994-07-05 ZA ZA944844A patent/ZA944844B/xx unknown
- 1994-07-05 MX MX9405132A patent/MX9405132A/es unknown
-
1996
- 1996-01-05 NO NO960056A patent/NO305029B1/no unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1463883A (fr) * | 1964-09-08 | 1966-07-22 | Ciba Geigy | Procédé de préparation de triaza-composés bicycliques |
US4450164A (en) * | 1981-01-13 | 1984-05-22 | Schering Corporation | Imidazo[1,2-A]pyridines and use |
US4419359A (en) * | 1981-02-11 | 1983-12-06 | Richter Gedeon Vegyeszeti Gyar Rt | Nitro-substituted polycyclic derivatives useful in the treatment of psoriasis |
US4492695A (en) * | 1982-04-21 | 1985-01-08 | Synthelabo | Therapeutically useful imidazo[1,2-a]pyridine derivatives |
SU1450746A3 (ru) * | 1985-04-25 | 1989-01-07 | Бристоль-Мейерз Компани (Фирма) | Способ получени производных 1,3-дигидро-2Н-имидазо/4,5-в/хинолин-2-онов или их фармацевтически приемлемых солей |
Non-Patent Citations (1)
Title |
---|
Chemical Abstracts, 1977, vol. 86, N 5, nо 29, с.733. * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2230553C2 (ru) * | 1997-09-26 | 2004-06-20 | Центарис АГ | Способ модулирования функции серин/треонин протеинкиназы соединением на основе азабензимидазола, способ идентификации соединений, модулирующих функцию серин/треонин протеинкиназы, способ профилактики или лечения патологических состояний в организме, соединение на основе азабензимидазола, способ его синтеза и фармацевтическая композиция |
RU2317988C2 (ru) * | 2000-08-14 | 2008-02-27 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные пиразолы, фармацевтическая композиция на их основе, применение фармацевтической композиции и способ ингибирования активности катепсина s |
RU2345993C2 (ru) * | 2001-09-21 | 2009-02-10 | Бристол-Маерс Сквибб Компани | ЛАКТАМСОДЕРЖАЩЕЕ СОЕДИНЕНИЕ И ЕГО ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa |
RU2390522C2 (ru) * | 2004-08-03 | 2010-05-27 | Палау Фарма, С.А. | Гетероциклические соединения |
RU2780338C2 (ru) * | 2017-05-31 | 2022-09-21 | Кемосентрикс, Инк. | 6-5 КОНДЕНСИРОВАННЫЕ КОЛЬЦА КАК ИНГИБИТОРЫ С5а |
Also Published As
Publication number | Publication date |
---|---|
NO960056L (no) | 1996-01-05 |
KR960703852A (ko) | 1996-08-31 |
JPH08507084A (ja) | 1996-07-30 |
NZ266525A (en) | 1997-10-24 |
CA2166721C (en) | 1999-07-27 |
EP0707585A1 (en) | 1996-04-24 |
NO960056D0 (no) | 1996-01-05 |
AU6805794A (en) | 1995-02-06 |
FI943208A0 (fi) | 1994-07-05 |
CN1048015C (zh) | 2000-01-05 |
NO305029B1 (no) | 1999-03-22 |
PL312426A1 (en) | 1996-04-29 |
AU695301B2 (en) | 1998-08-13 |
ZA944844B (en) | 1996-01-05 |
KR100228949B1 (ko) | 1999-11-01 |
WO1995001980A1 (en) | 1995-01-19 |
EG20513A (en) | 1999-06-30 |
CZ3696A3 (en) | 1997-06-11 |
IL110175A (en) | 2000-01-31 |
IL110175A0 (en) | 1994-10-07 |
CN1129940A (zh) | 1996-08-28 |
MX9405132A (es) | 1995-01-31 |
TW316904B (enrdf_load_stackoverflow) | 1997-10-01 |
HUT74170A (en) | 1996-11-28 |
CA2166721A1 (en) | 1995-01-19 |
BR9406946A (pt) | 1996-08-06 |
HU9503934D0 (en) | 1996-03-28 |
FI943208A7 (fi) | 1995-01-07 |
FI943208L (fi) | 1995-01-07 |
JP2944048B2 (ja) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2131876C1 (ru) | Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения | |
JP3000674B2 (ja) | ジヒドロピラゾロピロール類 | |
AU702105B2 (en) | Bicyclic tetrahydro pyrazolopyridines and their use as medicaments | |
EP0672031B1 (en) | Catechol diethers as selective pde iv inhibitors | |
RU2544011C2 (ru) | Триазолопиридины в качестве ингибиторов фосфодиэстеразы для лечения кожных заболеваний | |
KR100339935B1 (ko) | 치환된 인다졸 유도체, 및 포스포디에스테라제 4형 및 종양괴사 인자 형성의 억제제로서의 그의 용도 | |
AU2005278962A1 (en) | Isoindolin-1-one derivatives | |
JP2000502724A (ja) | インダゾール誘導体、およびホスホジエステラーゼ(pde)タイプ▲iv▼と腫瘍壊死因子(tnf)産生の阻害剤としてのインダゾール誘導体の使用 | |
JP2011528372A (ja) | α7ニコチン性アセチルコリンレセプターインヒビター | |
WO2012165399A1 (ja) | イミダゾピリジン化合物 | |
JP2010518026A (ja) | ナトリウムチャネルが介在する疾患または状態の治療に有用なピリドピリミジノン化合物 | |
US20030181472A1 (en) | Inflammation modulators | |
BG99879A (bg) | Инхибитори на нiv реверсивна транскриптаза | |
TWI659022B (zh) | 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物 | |
AU9240298A (en) | Bicyclic tetrahydro pyrazolopyridines and their use as medicaments | |
CA2201728A1 (en) | Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |